The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine.
D000293:Adolescent; D001835:Body Weight; D002648:Child; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006826:Hycanthone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007273:Injections, Intramuscular / Q000009:adverse effects; D007630:Kenya; D008297:Male; D009600:Nitroquinolines / Q000627:therapeutic use*; D010073:Oxamniquine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010146:Pain; D012550:Schistosoma mansoni / Q000187:drug effects; D012552:Schistosomiasis / Q000188:drug therapy*; D013892:Thioxanthenes / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced
D009600:Nitroquinolines; D013892:Thioxanthenes; D010073:Oxamniquine; D006826:Hycanthone